| |
 |
Professor Thomas Leung, DPhil (PhD)
The Lo Ka Chung Charitable Foundation Endowed Professor in Pharmaceutical Sciences, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University
Hong Kong, China |
|
| |
| Biography: |
|
| |
| Professor Thomas YC Leung obtained his DPhil degree from Sir William Dunn School of Pathology of the University of Oxford. He joined the Department of Applied Biology and Chemical Technology of PolyU in 1996. Currently, he serves as The Lo Ka Chung Charitable Foundation Professor in Pharmaceutical Sciences and the Director of the Lo Ka Chung Centre for Natural Anti-Cancer Drug Development. Focusing on drug discovery and translational research, Professor Leung developed pegylated recombinant human arginase in collaboration with Dr Thomas Lo and Dr Paul Cheng. The research was based on his pioneering work indicating that human arginase can starve cancer cells to death whilst leaving normal cells unharmed. Phase 2 clinical trials in liver cancer patients are currently ongoing in Hong Kong. Recently, pegylated arginase became Hong Kong’s homegrown drug to receive Investigational New Drug approval from the U.S. Food and Drug Administration and thus clearing the way for clinical trials in the United States. Professor Leung has received numerous awards, including the Prize of the State of Geneva in 2009 and the Second Class Prize in Natural Science Award of the Higher Education Outstanding Scientific Research Output Awards from the Ministry of Education in 2013. |
| |
| Session: |
|
| |
| 21st November 2015 (Saturday) |
 |
09:00 – 10:00 |
|
| |
| Session II: Early Clinical Research on Asian Diseases |
| |
| |
| |
| |
| |
|
|
